Stock VER.H VERISANTE TECHNOLOGY INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Verisante Technology Inc. Toronto S.E.

Equities

VER.H

CA92346G2036

Advanced Medical Equipment & Technology

Delayed Toronto S.E.
Other stock markets
 09:30:05 2024-04-25 am EDT 		5-day change 1st Jan Change
0.01 CAD 0.00% Intraday chart for Verisante Technology Inc. 0.00% -33.33%
Apr. 20 Verisante Technology Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 30 Verisante Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 0.0133 0.013 0.000126 0.1021 0.4792 0.000505
Enterprise Value (EV) 1 0.0703 0.0699 0.000126 -0.0354 0.3934 -0.0299
P/E ratio 0.03 x -0.26 x -0 x -0.53 x 0.2 x -0 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA -0.22 x -0.45 x - - - -
EV / FCF -0.06 x -0.58 x -0 x 0.25 x -1.82 x 0.36 x
FCF Yield -1,670% -173% -86,493% 407% -55.1% 280%
Price to Book -0.01 x -0.01 x -0 x -0.07 x -99.6 x -0.04 x
Nbr of stocks (in thousands) 9,862 9,862 9,862 9,862 32,738 38,338
Reference price 2 0.001348 0.001315 0.000013 0.0103 0.0146 0.000013
Announcement Date 1/31/22 2/2/22 2/2/22 2/7/22 3/20/23 3/29/24
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - - - - - -
EBITDA 1 -0.3213 -0.1544 - - - -
EBIT 1 -0.3214 -0.1545 -0.1514 -0.1845 -0.288 -0.1281
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 0.4314 -0.0496 -0.044 -0.1923 1.202 -0.0905
Net income 1 0.4314 -0.0496 -0.044 -0.1923 1.202 -0.0905
Net margin - - - - - -
EPS 2 0.0437 -0.005033 -0.004458 -0.0195 0.0728 -0.002656
Free Cash Flow 1 -1.173 -0.1211 -0.1087 -0.1441 -0.2167 -0.0836
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 1/31/22 2/2/22 2/2/22 2/7/22 3/20/23 3/29/24
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 0.06 0.06 - - - -
Net Cash position 1 - - - 0.14 0.09 0.03
Leverage (Debt/EBITDA) -0.1773 x -0.3689 x - - - -
Free Cash Flow 1 -1.17 -0.12 -0.11 -0.14 -0.22 -0.08
ROE (net income / shareholders' equity) -23% 3.82% 3.27% 13.1% -154% 1,117%
ROA (Net income/ Total Assets) -61.6% -57.4% -800% -146% -154% -129%
Assets 1 -0.7008 0.0864 0.005496 0.1318 -0.782 0.0701
Book Value Per Share 2 -0.1300 -0.1300 -0.1400 -0.1600 -0 -0
Cash Flow per Share - - - 0.0100 0 0
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 1/31/22 2/2/22 2/2/22 2/7/22 3/20/23 3/29/24
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+9.06% 219B
DANAHER CORPORATION Stock Danaher Corporation
+7.38% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.17% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+25.18% 108B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.57% 63.06B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+12.49% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+0.06% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+13.36% 39.35B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. VRSEF Stock
  4. VER.H Stock
  5. Financials Verisante Technology Inc.